Board of Directors

Duncan Moore, BSc PhD – Chairman

Duncan is a Life Sciences industry expert. He is a partner of East West Capital and an adviser to Ondra Partners. Prior to that he was a Managing Director at Morgan Stanley International where he was Global Head of Healthcare Research. During this time he led the equity market positioning of a number of major healthcare companies including Wellcome Plc, Sulzer Medica, Almirall and Grupo Rovi. He trained as a biochemist at the University of Leeds and has a PhD from the University of Cambridge. Whilst at Cambridge he co-founded a molecular diagnostics company with two colleagues. Following his move to the Capital Markets in 1985 he was involved in setting up the Bank Invest BioVenture funds and sat on the Board of these funds until they were sold in 2009. Duncan joined the Lamellar Board in December 2012 and was then appointed Chairman.

Alec McLean, BSc PhD – CEO

Alec has more than 30 years’ experience in respiratory research covering 9 years basic clinical pulmonary research at Edinburgh University Medical School, 9 years drug development with Astra Pharmaceuticals and 14 years in the CRO industry at Quintiles. This included extensive Phase 1-4 global clinical drug development, as Senior Director for global Allergy and Respiratory project management as well as commercial input, product development strategy and product and company due diligence. At any one point in time the value of the studies he had P&L responsibility for exceeded $300m, with yearly sales typically around $100m. Alec delivered pivotal studies for a range of pharma companies from blue chip e.g. Roche, AZ, Merck, Novartis and J&J to emerging biotechs e.g. Vertex, Stallergenes and Inspire.

Alec Mackie, CA – Non-Executive Director

Alec is the Managing Director of Barwell Plc, a specialised investment holding company based in Glasgow, which he began in 1993. Barwell was a founder investor in Lamellar. Alec acts as Lamellar’s Finance Director and Company Secretary.

John Carney, BSc, M.Litt (Cantab) – Deputy Chairman

John has more than 35 years’ experience of achieving long-term value creation through building technology based enterprises in growth industries, including Life Sciences, ICT, Energy and specialist manufacturing. Formerly, John was an Investment Adviser to Lazard Development Capital and then a Director of Corporate Finance with Hoare Govett in London. John joined the Board in January 2013.

Gavin Clark, CLP – Non-Executive Director

Gavin is an experienced Life Sciences licensing and business development professional. Presently, Gavin is Managing Director of Marlin Bioconsulting. Formerly, Gavin was Vice President of Business Development for Tibotec-Virco NV and before that Commercial Director of Phares Technology BV. Previously, he was responsible for Global Licensing Infectious Diseases at Glaxo Wellcome Plc and held senior marketing and commercial management posts with Ciba Pharmaceuticals, Bayer UK and Janssen Pharmaceuticals. Gavin is a Certified Licensing Professional as accredited by the Licensing Executives Society (USA and Canada). He joined the Board in April 2013.